Artificial Intelligence in Healthcare Market Rapid Growth with Leading Companies: IBM Corporation, Google, Inc., NVIDIA Corporation, Microsoft Corporation, iCarbonX, Next IT Corp

Increasing application of AI technologies, from pharma drug development to patient care is expected to support growth of artificial intelligence in healthcare market. Moreover, increasing number of collaborations among leading AI vendors and life sciences companies may help in rapid introduction of AI in medical devices and drug development. Pharmaceutical organizations can speed up the process of drug development, from drug discovery to commercialization, by using artificial intelligence. It can aid in development of personalized medicine. It is also increasingly being used for applications in advanced disease management such as cancer diagnosis and treatment, as studies have suggested that artificial intelligence may detect breast cancer spread to lymph nodes.

Get a Request Sample of Research Report @ www.coherentmarketinsights.com/insight/request-sample/436

For instance, Researchers from MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL), Harvard Medical School and Massachusetts General Hospital collaborated to apply AI in detection and diagnosis of breast cancer. The model developed by these scientists correctly diagnosed 97% of the cases. Artificial intelligence holds major potential in medical imaging and diagnosis of the diseases. Therefore, government organizations are increasing research in this field. For instance, In October 2017, National Clinical Research Center for Cancer (NCRCC) in China signed a deal with the Institute of Computing Technology under the Chinese Academy of Sciences (CAS), in order to use artificial intelligence in medical imaging.

Increasing research and development by leading players in In AI for healthcare application is expected to support growth of the artificial intelligence in healthcare market. IBM Corporation partnered with University of California, in order to enhance quality of life through artificial intelligence in October 2017. Moreover, IBM Watson and Massachusetts Institute of Technology (MIT) collaborated for joint research in artificial intelligence in September 2017. Two Israel based startups — CLEW Medical and Viz.ai — launched predictive analytics platform and direct-to-intervention system to automatically analyze brain CTs respectively, in January 2018.

Request for Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/436

Furthermore, Seegene, Inc. successfully developed molecular diagnostic assays by using artificial intelligence-based assay development system in January 2018. In May 2017, CJ Healthcare Corporation — a South Korea-based company — partnered with Syntekabio, Inc. to co-develop a new anticancer immunotherapy using artificial intelligence model.

Key players in the market are focusing on partnership and new product launch strategies, in order to enhance their market share. For instance, in 2017, NVIDIA Corporation partnered with GE Healthcare and Nuance to integrate NVIDIA’s deep learning platform with GE Healthcare medical imaging devices. Atomwise, Inc. launched a research program to accelerate drug discovery by using artificial intelligence in April 2017. Partners Connected Health and Hitachi Ltd. developed an artificial intelligence (AI) technology, which can predict hospital readmissions within 30 days for heart failure patients.

Manufacturers are focusing on integrating artificial intelligence with healthcare systems through natural language processing, machine learning, and algorithms. For instance, ExcelMedical received approval from the U.S. Food & Drug Administration (FDA) for Wave Clinical Platform in January 2018. This is an algorithm, which can predict sudden heart attacks and respiratory failure based on patient’s vitals. Deep Genomics, Inc. raised US$ 13 million in September 2017, to develop genetic medicines by using their artificial intelligence technology. Oncora Medical raised US$ 1.2 million to further develop its radiation oncology platform in 2016 using AI.

Inquire about Discount on this Report @ www.coherentmarketinsights.com/insight/request-discount/436

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.